Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation

Research output: Contribution to journalJournal articleResearchpeer-review

  • David M. Smadja
  • Peter Ivak
  • Yuri Pya
  • Christian Latremouille
  • Gustafsson, Finn
  • Jean Christian Roussel
  • Andre Vincentelli
  • Erwan Flecher
  • Piet Jansen
  • Ivan Netuka
Original languageEnglish
JournalJournal of Heart and Lung Transplantation
Volume41
Issue number9
Pages (from-to)1214-1217
Number of pages4
ISSN1053-2498
DOIs
Publication statusPublished - 2022

    Research areas

  • anticoagulation, low molecular weight heparin, total artificial heart

ID: 322282083